scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...989338Z |
P356 | DOI | 10.1371/JOURNAL.PONE.0089338 |
P932 | PMC publication ID | 3929710 |
P698 | PubMed publication ID | 24586699 |
P5875 | ResearchGate publication ID | 260447971 |
P50 | author | Yuji Kuge | Q100497115 |
Nagara Tamaki | Q112438951 | ||
Songji Zhao | Q121411256 | ||
P2093 | author name string | Toru Nakano | |
Yan Zhao | |||
Yoshikazu Tanaka | |||
Hiroshi Takemoto | |||
Tetsuya Yoshida | |||
Tatsuo Kobayashi | |||
Ayahisa Watanabe | |||
Keita Fukao | |||
P2860 | cites work | Comparing angiotensin II receptor blockers on benefits beyond blood pressure | Q30360678 |
Vascular inflammation and the renin-angiotensin system | Q33960784 | ||
Localization of deoxyglucose and annexin A5 in experimental atheroma correlates with macrophage infiltration but not lipid deposition in the lesion | Q50567621 | ||
Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice. | Q50698610 | ||
Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. | Q51320363 | ||
Angiotensin II Type 1 Receptor Blockade Does Not Enhance Apoptotic Cell Death During Ischemia and Reperfusion in Humans In Vivo | Q57779571 | ||
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis | Q63365783 | ||
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? | Q71749211 | ||
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE | Q73575738 | ||
Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study | Q80183412 | ||
Rosiglitazone, a PPAR-γ agonist, inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes | Q85071634 | ||
Impact of medical therapy on atheroma volume measured by different cardiovascular imaging modalities | Q34018909 | ||
Demonstration of all connective tissue elements in a single section; pentachrome stains. | Q34237133 | ||
Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease | Q35845567 | ||
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease | Q36511499 | ||
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies | Q37158159 | ||
In vivo detection and imaging of phosphatidylserine expression during programmed cell death | Q37403902 | ||
Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice | Q38300981 | ||
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging | Q38469591 | ||
A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects | Q39674136 | ||
Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. | Q40011856 | ||
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations | Q41687064 | ||
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice | Q42656141 | ||
Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity | Q42807756 | ||
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients | Q44574645 | ||
Attenuation of apoptosis by telmisartan in atherosclerotic plaques of apolipoprotein E-/- mice: evaluation using technetium 99m-annexin A5. | Q45069731 | ||
Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice | Q46231951 | ||
Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease | Q46833419 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | e89338 | |
P577 | publication date | 2014-02-19 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. | |
P478 | volume | 9 |
Q50200870 | A Comparison of [(99m)Tc]Duramycin and [(99m)Tc]Annexin V in SPECT/CT Imaging Atherosclerotic Plaques |
Q47866518 | A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque |
Q52577506 | Annexins in Glaucoma. |
Q39728613 | Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin |
Q39043966 | Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging |